Actually Red Ace I do remember reading about Mesoblast - MSB.ASX, a biotech company that has a market cap of $1.76Billion (11x higher than UNS). IT’S TRADING AT $5.66, It registered a higher loss (60Mil) and are trading at 10X the price of Unilife. I guess when you put it in those terms what should UNS be worth? Deutcher Bank values MSB unrisked at $8.20 and at $92.20 if they reach their potential. Have a think about this information for Unilife. Could this eventually be the case at some time in the future with Unilife? Perhaps so, who knows? I think over the coming days the real journo’s and analysts will take a balanced unbiased view of this company and start to put in the right perspective.
UNS Price at posting:
56.0¢ Sentiment: Buy Disclosure: Held
